These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 8500854)
1. Is endothelin involved in the pathogenesis of hypertension? Vanhoutte PM Hypertension; 1993 Jun; 21(6 Pt 1):747-51. PubMed ID: 8500854 [TBL] [Abstract][Full Text] [Related]
2. Role of endothelin in the control of peripheral vascular tone in human hypertension. Taddei S; Virdis A; Ghiadoni L; Sudano I; Magagna A; Salvetti A Heart Fail Rev; 2001 Dec; 6(4):277-85. PubMed ID: 11447302 [TBL] [Abstract][Full Text] [Related]
3. Endothelin as a regulator of cardiovascular function in health and disease. Haynes WG; Webb DJ J Hypertens; 1998 Aug; 16(8):1081-98. PubMed ID: 9794709 [TBL] [Abstract][Full Text] [Related]
7. Endothelin and endothelin antagonists: potential role in cardiovascular and renal disease. Noll G; Wenzel RR; Lüscher TF Mol Cell Biochem; 1996 Apr 12-26; 157(1-2):259-67. PubMed ID: 8739256 [TBL] [Abstract][Full Text] [Related]
8. Endothelium-derived vasoactive factors in hypertension: nitric oxide and endothelin. Nava E; Lüscher TF J Hypertens Suppl; 1995 Aug; 13(2):S39-48. PubMed ID: 8576787 [TBL] [Abstract][Full Text] [Related]
9. Vascular endothelin in hypertension. Schiffrin EL Vascul Pharmacol; 2005 Jun; 43(1):19-29. PubMed ID: 15955745 [TBL] [Abstract][Full Text] [Related]
10. Endothelins and anti-endothelins. Bhatt AD J Assoc Physicians India; 1997 Nov; 45(11):868-72. PubMed ID: 11229190 [TBL] [Abstract][Full Text] [Related]
11. [Endothelin, a peptidic vasoconstrictor]. Dousset B; Jacob C Presse Med; 1992 Apr; 21(14):665-9. PubMed ID: 1317961 [TBL] [Abstract][Full Text] [Related]
12. Circulatory and myocardial effects of endothelin. Krämer BK; Ittner KP; Beyer ME; Hoffmeister HM; Riegger GA J Mol Med (Berl); 1997; 75(11-12):886-90. PubMed ID: 9428621 [TBL] [Abstract][Full Text] [Related]
13. Endothelin: potential role in hypertension and vascular hypertrophy. Schiffrin EL Hypertension; 1995 Jun; 25(6):1135-43. PubMed ID: 7768553 [TBL] [Abstract][Full Text] [Related]
14. Endothelin: systemic arterial and pulmonary effects of a new peptide with potent biologic properties. Lüscher TF Am Rev Respir Dis; 1992 Nov; 146(5 Pt 2):S56-60. PubMed ID: 1332560 [TBL] [Abstract][Full Text] [Related]
15. Endothelium-dependent vascular activities of endothelin-like peptides in the isolated superior mesenteric arterial bed of the rat. Douglas SA; Hiley CR Br J Pharmacol; 1990 Sep; 101(1):81-8. PubMed ID: 2282471 [TBL] [Abstract][Full Text] [Related]
18. [Endothelin: the vasoconstrictor of the 1990's?]. Cacoub P; Carayon A; Dorent R; Nataf P; Chemlal K; Maistre G; Piette JC; Godeau P Rev Med Interne; 1993 Apr; 14(4):229-32. PubMed ID: 8378653 [TBL] [Abstract][Full Text] [Related]
19. Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney. Wellings RP; Corder R; Warner TD; Cristol JP; Thiemermann C; Vane JR Br J Pharmacol; 1994 Feb; 111(2):515-20. PubMed ID: 8004396 [TBL] [Abstract][Full Text] [Related]